LUZZI, ROBERTA
 Distribuzione geografica
Continente #
NA - Nord America 1.911
AS - Asia 1.346
EU - Europa 1.298
SA - Sud America 365
OC - Oceania 24
AF - Africa 19
Continente sconosciuto - Info sul continente non disponibili 4
AN - Antartide 1
Totale 4.968
Nazione #
US - Stati Uniti d'America 1.875
SG - Singapore 529
CN - Cina 345
BR - Brasile 298
IE - Irlanda 261
IT - Italia 228
UA - Ucraina 186
TR - Turchia 149
SE - Svezia 147
VN - Vietnam 128
DE - Germania 102
GB - Regno Unito 88
FR - Francia 65
IN - India 50
RU - Federazione Russa 46
ES - Italia 45
HK - Hong Kong 43
FI - Finlandia 40
AR - Argentina 33
PL - Polonia 30
AU - Australia 24
EC - Ecuador 17
ID - Indonesia 17
JP - Giappone 15
CA - Canada 13
MX - Messico 13
AT - Austria 10
BD - Bangladesh 10
CZ - Repubblica Ceca 9
PT - Portogallo 9
ZA - Sudafrica 9
KR - Corea 8
BE - Belgio 7
IQ - Iraq 7
NL - Olanda 7
CO - Colombia 6
IR - Iran 6
TW - Taiwan 6
PK - Pakistan 5
RO - Romania 5
TH - Thailandia 5
NI - Nicaragua 4
MA - Marocco 3
MY - Malesia 3
PY - Paraguay 3
SA - Arabia Saudita 3
UZ - Uzbekistan 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
CH - Svizzera 2
CL - Cile 2
EG - Egitto 2
EU - Europa 2
HR - Croazia 2
JM - Giamaica 2
JO - Giordania 2
LT - Lituania 2
OM - Oman 2
PA - Panama 2
PE - Perù 2
SI - Slovenia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AQ - Antartide 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BH - Bahrain 1
CG - Congo 1
DK - Danimarca 1
DZ - Algeria 1
GR - Grecia 1
HU - Ungheria 1
IL - Israele 1
KE - Kenya 1
KW - Kuwait 1
NP - Nepal 1
PH - Filippine 1
PS - Palestinian Territory 1
QA - Qatar 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 4.968
Città #
Singapore 355
Jacksonville 274
Chandler 258
Dublin 250
Dallas 121
Princeton 108
Nanjing 79
Ashburn 76
Beijing 73
Izmir 71
Altamura 52
Ho Chi Minh City 52
Santa Clara 52
Wilmington 52
Los Angeles 44
Cambridge 41
Hong Kong 41
Nanchang 38
Ann Arbor 37
New York 34
Catania 31
Southend 30
Dearborn 27
Hanoi 27
Menlo Park 26
The Dalles 22
Tongling 21
São Paulo 20
Redondo Beach 19
Santa Pola 18
Boardman 16
Rio de Janeiro 15
Warsaw 15
Buffalo 13
Shenyang 13
Stoke-on-Trent 13
Calpe 12
Hebei 12
Munich 12
Kunming 11
Chieti 10
Jiaxing 10
Milan 10
Shanghai 10
Curitiba 9
Da Nang 9
Denver 9
Tokyo 9
Washington 9
Helsinki 8
Istanbul 8
Quito 8
Brussels 7
Frankfurt am Main 7
Houston 7
Belo Horizonte 6
Haiphong 6
Johannesburg 6
Orem 6
Phoenix 6
Rome 6
San Mateo 6
Seattle 6
Tianjin 6
Brno 5
Brooklyn 5
Chennai 5
Falls Church 5
Jakarta 5
Kraków 5
Lanzhou 5
Montreal 5
Offenbach 5
Poplar 5
San Michele al Tagliamento 5
Surfers Paradise 5
Toronto 5
Vienna 5
Woodbridge 5
Atlanta 4
Biên Hòa 4
Brasília 4
Bắc Ninh 4
Changsha 4
Darmstadt 4
Hangzhou 4
Hanover 4
Juiz de Fora 4
Madrid 4
Managua 4
Melbourne 4
Mérignac 4
North Kingstown 4
Norwalk 4
Recife 4
San Jose 4
Uberlândia 4
Americana 3
Amsterdam 3
Ankara 3
Totale 2.821
Nome #
Pycnogenol® supplementation prevents inflammation and symptoms in recurrent, non-severe urinary infections 188
Beanblock® (standardized dry extract of Phaseolus vulgaris) in mildly overweight subjects: a pilot study. 177
Effects of collagen remodulation with Centella asiatica (Centellicum®) in Dupuytren palmar fibromatosis: a pilot supplement study 155
Robuvit® (Quercus robur extract) supplementation in subjects with chronic fatigue syndrome and increased oxidative stress. A pilot registry study 146
Aescin and microcirculatory activity. Effects of accessory components on clinical and microcirculatory efficacy. 143
Moderate, diffuse, somatic muscular pain: Effects of supplementation with a Pycnogenol patch 125
Pycnogenol® and Centella asiatica to prevent asymptomatic atherosclerosis progression in clinical events 125
An open, supplement, registry study Arborvitae (R) for prevention of arthrosis-related pain during exercise 123
Management of Varicose Veins and Chronic Venous Insufficiency in a Comparative Registry with Nine Venoactive Products in Comparison with Stockings 120
Improvement in mood, oxidative stress, fatigue, and insomnia following supplementary management with Robuvit® 118
Effects of pycnogenol on endothelial dysfunction in borderline hypertensive, hyperlipidemic, and hyperglycemic individuals: the borderline study. 117
Management of functional, hepatic damage after chemotherapy with Liverubin (pharma-standard silymarin). 113
Bilberry extracts are not created equal: the role of non anthocyanin fraction. Discovering the "dark side of the force" in a preliminary study 112
Temporary kidney dysfunction: Robuvit® supplementation in initial, transient kidney insufficiency and micro-macro albuminuria 112
Clinical improvement in chronic venous insufficiency signs and symptoms with Venoruton® (HR): an 8-month, open-registry, cost-efficacy study. 111
Management of mild, primary Raynaud Syndrome: supplementation with Pycnogenol (R) 107
A natural pharma standard supplement formulation to control treatment-related toxicity and oxidative stress in genitourinary cancer: a preliminary study 104
Recurrence of retinal vein thrombosis with Pycnogenol® or Aspirin® supplementation: a registry study 100
Pycnogenolà supplementation improves health risk factors in subjects with metabolic syndrome 100
Ethnomedicine and phytochemistry of the genus Potentilla 99
Improvement of common cold with Pycnogenol®: a Winter registry study. 99
Improvement in signs and symptoms in psoriasis patients with Pycnogenol® supplementation. 99
Robuvit®: improvement of fatigue in medical convalescence. 98
Delayed progression of atherosclerosis and cardiovascular events in asymptomatic patients with atherosclerotic plaques; 3-year prevention with the supplementation with Pycnogenol®+Centellicum® 98
Phytochemical investigation on Gentian roots from populations of Gran Sasso and Monti della Laga National Park 96
Supplementation with Robuvit® in subjects with burnout associated to high oxidative stress 93
Supplementary management of functional, hepatic damage with Liverubin (pharma-standard Silymarin). A 3-month registry. 92
Primary benign back pain: supplementation with Pycnogenol® 92
Pycnogenol®+Centellicum®, post-stent evaluation: prevention of neointima and plaque re-growth 90
Lady Prelox® improves sexual function in generally healthy women of reproductive age. 88
Managing ulcerative colitis in remission phase: usefulness of Casperome®, an innovative lecithin-based delivery system of Boswellia serrata extract 87
Topical formulation of heparin is effective in reducing the symptoms of superficial venous thrombosis: a monocenter, observer-blind, placebo-controlled randomized study. 86
Pycnogenol® supplementation in minimal cognitive dysfunction 85
Pycnogenol® in postpartum symptomatic hemorrhoids. 84
The Efficacy of Sulodexide in the Prevention of Postthrombotic Syndrome 84
Osteoporosis of the jaw. Product evaluation: mf Odontovis Calcium®. 83
[Severe intermittent claudication: PGE1 treatment. A 40-week registry, efficacy and costs]. 82
Improved management of primary chronic fatigue syndrome with the supplement French oak wood extract (Robuvit®): a pilot, registry evaluation. 79
Pycnogenol® improvements in asthma management. 79
The Efficacy of Sulodexide in the Prevention of Postthrombotic Syndrome. 78
Prevention of post thrombotic syndrome with Pycnogenol® in a twelve month study. 74
Venoruton®: post thrombotic syndrome. Clinical improvement in venous insufficiency (signs and symptoms) with Venoruton®. A five-year, open-registry, efficacy study. 73
Normalization of cardiovascular risk factors in peri-menopausal women with Pycnogenol® 72
Meriva®, a lecithinized curcumin delivery system, in the control of benign prostatic hyperplasia: a pilot, product evaluation registry study. 70
Pycnogenol and Centella Asiatica for preventing asymptomatic atherosclerosis progression into clinical events. 70
Pycnogenol® improves cognitive function, attention, mental performance and specific professional skills in healthy professionals aged 35-55. 70
Pycnogenol® supplementation improves cognitive function, attention and mental performance in students. 70
Product evaluation of Ureadin Rx Db (ISDIN) for prevention and treatment of mild-to-moderate xerosis of the foot in diabetic patients. Prevention of skin lesions due to microangiopathy. 69
Meriva®+Glucosamine versus Condroitin+Glucosamine in patients with knee osteoarthritis: an observational study. 68
Pycnogenol® and Centella Asiatica for asymptomatic atherosclerosis progression. 68
Improvements of venous tone with pycnogenol in chronic venous insufficiency: an ex vivo study on venous segments. 67
Meriva®, a lecithinized curcumin delivery system, in diabetic microangiopathy and retinopathy. 62
Prevention of flu episodes with colostrum and Bifivir compared with vaccination: an epidemiological, registry study. 59
Totale 5.159
Categoria #
all - tutte 20.212
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.212


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021127 0 0 0 0 0 64 5 9 10 9 19 11
2021/2022230 9 7 0 42 21 8 13 15 11 7 32 65
2022/2023763 67 110 34 78 68 152 45 66 95 13 26 9
2023/2024401 21 17 30 13 24 84 146 19 9 11 3 24
2024/2025957 64 181 142 29 35 23 19 43 160 36 79 146
2025/20261.197 119 88 287 428 222 53 0 0 0 0 0 0
Totale 5.159